Module II (INV) is associated with high expression of FN1, a marker gene of epithelial-mesenchymal transition (EMT) [22], which is closely related to tumorigenesis, invasion and metastasis, and predicts poor outcome of breast cancer[81–83]. Here, FN1 is linked to breast cancer.